Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(7%)
Results Posted
44%(4 trials)

Phase Distribution

Ph phase_3
1
7%
Ph phase_4
2
14%
Ph not_applicable
4
29%
Ph phase_2
7
50%

Phase Distribution

0

Early Stage

7

Mid Stage

3

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
7(50.0%)
Phase 3Large-scale testing
1(7.1%)
Phase 4Post-market surveillance
2(14.3%)
N/ANon-phased studies
4(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(9)
Other(4)

Detailed Status

Completed9
unknown3
Suspended1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 27 (50.0%)
Phase 31 (7.1%)
Phase 42 (14.3%)
N/A4 (28.6%)

Trials by Status

completed964%
suspended17%
active_not_recruiting17%
unknown321%

Recent Activity

1 active trials
Showing 5 of 14
active_not_recruitingnot_applicable

Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers

NCT00682318
completednot_applicable

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)in Tokyo: Open Trial

NCT07013981
completednot_applicable

Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus

NCT06061510
completedphase_2

Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids

NCT01027143
suspendedphase_2

Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome

NCT04518319
View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials
NCT00682318Not Applicable

Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers

Active Not Recruiting
NCT07013981Not Applicable

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)in Tokyo: Open Trial

Completed
NCT06061510Not Applicable

Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus

Completed
NCT01027143Phase 2

Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids

Completed
NCT04518319Phase 2

Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome

Suspended
NCT04572789Not Applicable

Omega-3 Fatty Acid in the Prevention of Migraine

Completed
NCT01733147Phase 4

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Completed
NCT03093246Phase 2

Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis

Completed
NCT03093207Phase 2

Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis

Completed
NCT02166424Phase 3

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO)

Completed
NCT01948596Phase 2

The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO): Open Trial

Completed
NCT01910948Phase 4

Perioperative Application of Omega-3 Polyunsaturated Fatty Acids in Gastric Cancer Patients

Unknown
NCT00289484Phase 2

A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression

Unknown
NCT00238758Phase 2

A Study of Omega-3 as a Treatment for Major Depression

Unknown

All 14 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
14